Abstract
Packaging is an integral part of any medicinal product. Not only from a regulatory point of view, but also that of the patient. It is only the packaged medicinal product which is stable and suitable for use. The stability of the product follows from the successful combination of formulation, packaging materials and method of production. The correct choice of container and closure system will impact every aspect of product life and usage. This is true for industrial as well as pharmacy (re-) packaged products.
Packaging technology encompasses knowledge from the fields of material science, chemistry, engineering and ergonomy. With appropriate development, the packaging system, and the many different functions it serves will go virtually unnoticed. However, an unsuitable packaging system will result in the product’s failure to meet the patient’s needs.
This chapter aims to introduce the reader to the many different aspects of pharmaceutical packaging technology. It provides basic and applied knowledge and will enable the right choice of container system for almost every medicinal product found in the pharmacy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Beyrich TH, Tilbussek P (1981) Untersuchungen zur Lichtdurchlässigkeit eingefärbter Plastflaschen. Pharmazie 36(5):337–341
Guideline on the Packaging Information of Medicinal Products for Human Use Authorised by the Union. European commission, Revision 14.4, December 2016
Guideline on the Readability of the Label and Package Leaflet of Medicinal Products for Human Use. European Commission, Revision 1, January 2009
Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668), European Commission, November 2019
Good Manufacturing Practice Guidelines (EudraLex Vol.4). http://ec.europa.eu/health/medicinal-products/eudralex/eudralex-volume-4_en. Accessed 18 Jan 2022
EU-GMP Annex 13: Investigational medicinal products. https://www.gmp-compliance.org/files/guidemgr/2009_06_annex13.pdf. Accessed 18 Jan 2022
Ph. Eur. Materials used for the manufacture of containers (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Abendroth RP, Clark RN (1992) Glass containers for parenterals. In: Avis KE, Lieberman HA, Lachman L (eds) Pharmaceutical dosage forms: parenteral medications, vol 1, 2nd edn. Marcel Dekker, New York, pp 361–385
ICH Guideline Q3D (R1) on elemental Impurities, EMA/CHMP/ICH/353369/2013 Committee for Human Medicinal Products March 2019
Surmann JP (1992) BosseI. Abfall des pH-wertes wässriger Salzlösungen in ampullen. Pharm Ind 54:66–68
Bohrer D, Cicero do Nascimento P, Binotto R, Pomblum SC (2001) Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part I: salts, glucose, heparin and albumin. J Trace Elem Med Biol 15:95–101
Bohrer D, Cicero do Nascimento P, Binotto R, Carlesso R (2001) Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition. J Trace Elem Med Biol 15:103–108
Bohrer D, Cicero do Nascimento P, Binotto R, Becker E (2003) Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container-chemicals during the heating for sterilisation. J Trace Elem Med Biol 17(2):107–115
Ruijgrok EJ, van der Hoeven RTM, Boer Y (1996) Farmaceutisch onderzoek van een intraoculaire spoelvloeistof. Ziekenhuisfarmacie 12:37–39
Boer Y, Ramondt AA (1992) Bestendigheid van Duran®-flessen tegen borax, boorzuur en water. Pharm Weekbl 127:6–9
Klein GL (2005) Aluminium: new recognition of an old problem. Curr Opin Pharmacol 5:637–640
Smith BS, Kothari H, Hayes BD, Tataronis G, Hudlin M, Doole J, Hartman C (2007) Effect of additive selection on calculated aluminium content of parenteral nutrient solutions. Am J Health Syst Pharm 64:730–739
Ph. Eur. Glass containers for pharmaceutical use (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Büsing G, Grigat H, Schultz D, Hundertmark F-D, Ramd J (1988) Methoden zur Verbesserung der hydrolytischen Beständigkeit von Kalknatronglas. Pharm Ind 50:1173–1178
Bootsma HPR, Kaufmann BG, Boeke AW, van de Poll MAPC (1991) De afgifte van silicaat uit infusieflessen. Ziekenhuisfarmacie 7:113–117
Jongejan GAM, Smit JCA, Helling EAM, Hekster YA (1989) De wisselwerking tussen geneesmiddelen en kunststoffen voor medisch gebruik. Pharm Weekbl 124:440–444
Zeidler C, Dettmering D, Schrammel W, Spieteller M (1999) Compatibility of various drugs in intensive care medicine in polyethylene, pvc and glass infusion containers. Eur J Hosp Pharm 5(3):106–110
Medical Devices Containing DEHP Plasticised PVC (2002, September) Neonates and other groups possibly at risk from DEHP toxicity. European Commission
Bauer EJ (2009) Pharmaceutical packaging handbook. Informa Healthcare, New York
Flory PJ (1990) Principles of polymer chemistry, 14th edn. Cornell University Press, Ithaca
Murdan S (2018) Chapter 46: Packaging. In: Aulton ME, Taylor KMG (eds) Aulton’s pharmaceutics – the design and manufacture of medicines, 5th edn. Churchill, Livingstone, Elsevier, Edinburgh, pp 820–835
Kranich K (1985) Papier und karton für die pharmazeutische industrie. In: Helbig J, Spingler E (eds) Kunststoffe für die Pharmazeutische Verpackung. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp 76–77
EDQM. Pharmeuropa. Special issue. Standard terms, pharmaceutical dosage forms, routes of administration, containers. (Subscribers only) http://www.edqm.eu/StandardTerms
Van Santvliet L, Ludwig A (2004) Determination of eye drop size. Surv Ophtalmol 49:197–213
Ph. Eur. Eye Preparations (2020) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Neues Receptur-Formularium. DAC/NRF 2007. Alg Teil III Rezepturbestandteile und Packmittel: 11
Nannan Panday PV, van der Heiden J, Dillingh J, Wijdh RJ, Kosterink JGW, Schellekens RCA (2007) Microbiologische validatie van de oogdruppelflacon met snap-cap: de casus acetylcysteïneoogdruppels 5%. PW Wetensch Platf 1(1):16–21
Dampfsterilisation von Augentropfen/Konzentrationsänderungen bei autoklavierten Augentropfen. Pharm Zeit 1990;135:36–37
Ph. Eur. Parenteral Preparations (2015) European pharmacopoeia, 8th edn. Council of Europe, Strasbourg. 04/2015:0520
Ph. Eur. Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Oremus ETHGJ, Boom FA, Graatsma BH (1981) Bereiding van parenteralia in ziekenhuisapotheken. II Toetsing van recipienten. Pharm Weekbl 116:716–723
Boom FA, van der Veen J, Verbrugge P, Van der Vaart FJ, Paalman ACA, Vos TH (2000) Particulate matter determination in LVP’s produced in Dutch hospital pharmacies. Part 2: Overview of the results. J Pharm Sci Technol 54:343–358
Asche H, Gay A, Kabay A (1978) Einfluss des Behälters auf die Anfälligkeit von Dermatika- Grundlagen gegenüber microbieller Kontamination. Pharm Ind 40(112):1212–1217
The United States Pharmacopeia USP 36/The National Formulary NF 31 (2013) <751 > Metal particles in ophthalmic ointments. The United States Pharmacopeial Convention, Rockville, pp 334–335
van Geffen ECG, Meuwese E, Philbert D et al (2009) Problemen met verpakkingen van geneesmiddelen. Ervaringen gemeld bij het Meldpunt Medicijnen. PW Wetensch Platf 3(11):199–203
Ph. Eur. Preparations for irrigation (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Kalmeijer MD, Louwen J, Stuurman A (1999) Extractie van di(2-ethylhexyl)ftalaat uit pvc door de oplosmiddelen van paclitaxel, docetaxel en etoposide. De Farmacopee versus de praktijk. Pharm Weekbl 134:1143–1149
AG Arzneimitteltherapiesicherheit (2008) Orale Lösung intravenös appliziert. Krankenhauspharmazie 29(12):545–546
Ph. Eur. Powders for cutaneous application (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Ph. Eur. Liquid preparations for oral use (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Oogdruppelhulpmiddelen. In: Het oogziekenhuis Rotterdam. https://www.oogziekenhuis.nl/artikelen/hulpmiddelen-oogdruppelen.html. Accessed 19 Jan 2022
Buhrs E (2008) Nog veel te veel gepeuter. Pharm Weekbl 45:36–39
de Jong AP, Bogaards MJ, Boom FA (2002) Kwaliteitsborging van verpakkingsmateriaal. ‘Betrouwbare leverancier’ als hoeksteen. Pharm Weekbl 127:1035–1040
Committee for medicinal products for human use, (CHMP), Committee for medicinal products for veterinary use, (CVMP) (2005) Guideline on immediate packaging materials. European Medicines Agency, Amsterdam
Ph. Eur. pharmaceutical preparations; general notices (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Ph. Eur. Plastic containers and closures for pharmaceutical use (2022) European pharmacopoeia, 10th edn. Council of Europe, Strasbourg
Jenke D, Odufu A, Couch T et al (2012) Evaluation of the general solution compatibility of polymer materials used in medical devices such as syringes. PDA J Pharm Sci Technol 66:286–306. https://doi.org/10.5731/pdajpst.2012.00869
Jenke D, Castner J, Egert T et al (2013) Extractables characterization for five materials of construction representative of packaging systems used for parenteral and ophthalmic drug products. PDA J Pharm Sci Technol 67:448–511. https://doi.org/10.5731/pdajpst.2013.00933
Felsovalyi F, Janvier S, Jouffray S et al (2012) Silicone-oil-based subvisible particles: their detection, interactions, and regulation in prefilled container closure systems for biopharmaceuticals. J Pharm Sci 101:4569–4583. https://doi.org/10.1002/jps.23328
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Smith, J., Larmené-Beld, K. (2023). Containers. In: Le Brun, P., Crauste-Manciet, S., Krämer, I., Smith, J., Woerdenbag, H. (eds) Practical Pharmaceutics. Springer, Cham. https://doi.org/10.1007/978-3-031-20298-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-20298-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-20297-1
Online ISBN: 978-3-031-20298-8
eBook Packages: MedicineMedicine (R0)